Effectiveness of netakimab in psoriasis and psoriatic arthritis with concomitant metabolic syndrome
Vestnik dermatologii i venerologii · 28.03.2026 · 102 (1) · 68-75
DOI: 10.25208/vdv16953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vestnik dermatologii i venerologii, online erschienen am 28.03.2026. Verfasst von L. A. Novikova und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Psoriasis and psoriatic arthritis are characterized by a high prevalence, a chronic progressive course, the frequent presence of severe forms, comorbidities, and a significant decrease in patients’ quality of life, which justifies high demands on the efficacy and safety of therapy for these diseases. The article describes two clinical cases of the successful use of the interleukin 17 (IL-17) inhibitor netakimab in patients with psoriasis and psoriatic arthritis with concomitant metabolic syndrome. Netakimab was administered at a dose of 120 mg as subcutaneous injections once weekly on weeks 0, 1, and 2, followed by 120 mg once every 4 weeks. The treatment efficacy was assessed by clinical and laboratory examination using PASI, DAS28, and NAPSI scores. Netakimab treatment resulted in regression of subjective and objective skin symptoms and sustained clinical and laboratory remission of joint syndrome. Netakimab treatment was free of adverse events and significantly improved patients’ quality of life.
Zitieren
APA
Novikova, L. A., Dontsova, E. V., Bakhmetyev, A. A., Borzunova, L. N., Kuranosov, A. Y., & Voronkova, N. A. (2026). Effectiveness of netakimab in psoriasis and psoriatic arthritis with concomitant metabolic syndrome. Vestnik dermatologii i venerologii, 102(1), 68-75. https://doi.org/10.25208/vdv16953
Vancouver
Novikova LA, Dontsova EV, Bakhmetyev AA, Borzunova LN, Kuranosov AY, Voronkova NA. Effectiveness of netakimab in psoriasis and psoriatic arthritis with concomitant metabolic syndrome. Vestnik dermatologii i venerologii. 2026;102(1):68-75. doi:10.25208/vdv16953
BibTeX
@article{Novikova2026,
author = {Novikova, L. A. and Dontsova, E. V. and Bakhmetyev, A. A. and Borzunova, L. N. and Kuranosov, A. Yu. and Voronkova, N. A.},
title = {Effectiveness of netakimab in psoriasis and psoriatic arthritis with concomitant metabolic syndrome},
journal = {Vestnik dermatologii i venerologii},
year = {2026},
volume = {102},
number = {1},
pages = {68--75},
doi = {10.25208/vdv16953}
}
EUVIMED